Table 2.
Controls | Mild increase group | Advanced group | p‐Value* | p‐Value** | |
---|---|---|---|---|---|
Total (N) | 2506 | 1760 | 666 | ||
Prediabetes (%, 95% CI) |
9.4 (8.2–10.5) | 12.8 (11.2–14.3) | 18.9 (15.9–21.9) | <.01 | <.01 |
♂ (%, 95% CI) | 9.7 (7.8–11.5) | 12.5 (10.4–14.5) | 19 (15.4–22.5) | ||
♀ (%, 95% CI) | 9.2 (7.7–10.6) | 13.2 (10.8–15.7) | 18.8 (13.1–24.5) | ||
T2DM (%, 95% CI) | 1.3 (0.8–1.7) | 1 (0.5–1.4) | 3.0 (1.7–4.3) | .35 | <.01 |
♂ (%, 95% CI) | 1.1 (0.5–1.8) | 1.1 (0.4–1.7) | 2.1 (0.8–3.4) | ||
♀ (%, 95% CI) | 1.4 (0.8–2.0) | 0.8 (0.2–1.4) | 5.4 (2.1–8.6) |
Abbreviations: OGTT, oral glucose tolerance test; T2DM, type 2 diabetes mellitus.
p‐Value: Differences between the controls and mild increase group.
p‐Value: Differences between the controls and advanced group.